University of Kansas Medical Center

Early Apical Release vs Classic Holmium Laser Enucleation of the Prostate: Randomized Controlled Trial Comparing Post-Operative Incontinence Rates and Surgical Outcomes

Purpose

To determine if early apical release holmium enucleation of the prostate (EAR HoLEP), as a surgical treatment for benign prostatic hyperplasia, reduces post-operative urinary incontinence compared to classic HoLEP.

Condition

Benign Prostatic Hyperplasia

Eligibility

Eligible Ages: Over 18 Years
Eligible Sex: Male
Accepts Healthy Volunteers: No

Inclusion Criteria

Patients must be 18 years of age or older - Patients must present to clinic with a diagnosis of benign prostatic hyperplasia - Patients must be scheduled to undergo a holmium laser enucleation of the prostate

Exclusion Criteria

Patients with previous surgical management of BPH - Patients with prostate biopsy revealing high risk prostate cancer - Patients with a concomitant neurogenic bladder diagnosis (SCI, Parkinson, MS, cerebral palsy)

Study Design

Phase: N/A
Study Type: Interventional
Allocation: Randomized
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
Masking: Single (Participant)

Arm Groups

Arm	Description	Assigned Intervention
Experimental Early apical release holmium enucleation of the prostate	Early apical release holmium enucleation of the prostate (EAR HoLEP), as a surgical treatment for benign prostatic hyperplasia	Procedure: EAR HoLEP early apical release holmium enucleation of the prostate (EAR HoLEP), as a surgical treatment for benign prostatic hyperplasia
Active Comparator Classic holmium enucleation of the prostate	Classic holmium enucleation of the prostate (HoLEP), as a surgical treatment for benign prostatic hyperplasia	Procedure: Classic HoLEP classic holmium enucleation of the prostate as a surgical treatment for benign prostatic hyperplasia

More Details

Status: Completed
Sponsor: University of Kansas Medical Center

Study Contact

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.